Name
Osaühing Perearst Merike Roseniit
Registry code
10899585
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
18.12.2002 (21)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Merike Roseniit 06.05.1964 (60) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 17.06.2020 | 2020 17.08.2021 | 2021 22.07.2022 | 2022 19.07.2023 | |
|---|---|---|---|---|
| Total Revenue | 111 456 € | 189 598 € | 208 106 € | 225 072 € |
| Net profit (loss) for the period | 5 762 € | 82 823 € | 80 160 € | 87 484 € |
| Profit Margin | 5% | 44% | 39% | 39% |
| Current Assets | 85 605 € | 179 167 € | 166 910 € | 251 838 € |
| Fixed Assets | 12 432 € | 6 841 € | 105 483 € | 114 078 € |
| Total Assets | 98 037 € | 186 008 € | 272 393 € | 365 916 € |
| Current Liabilities | 7 071 € | 12 219 € | 18 444 € | 24 483 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 90 966 € | 173 789 € | 253 949 € | 341 433 € |
| Employees | 3 | 3 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 7 333.75 € | 7 827.74 € | 4 |
| 2023 Q4 | - | 8 785.35 € | 9 368.47 € | 4 |
| 2023 Q3 | - | 7 263.62 € | 7 760.76 € | 4 |
| 2023 Q2 | - | 7 113.25 € | 7 613.83 € | 4 |
| 2023 Q1 | - | 6 054.52 € | 6 475.61 € | 4 |
| 2022 Q4 | - | 8 294.92 € | 8 848.6 € | 3 |
| 2022 Q3 | - | 7 713.98 € | 8 201 € | 4 |
| 2022 Q2 | - | 6 623.97 € | 7 064.43 € | 4 |
| 2022 Q1 | - | 6 153.96 € | 6 595.22 € | 4 |
| 2021 Q4 | - | 5 480.96 € | 5 967.92 € | 5 |
| 2021 Q3 | - | 8 002.32 € | 8 700.28 € | 4 |
| 2021 Q2 | - | 6 282.76 € | 6 842.03 € | 4 |
| 2021 Q1 | - | 6 369.99 € | 6 936.6 € | 4 |
| 2020 Q4 | - | 5 491.81 € | 5 985.76 € | 4 |
| 2020 Q3 | - | 5 068.05 € | 5 529.48 € | 3 |
| 2020 Q2 | - | 5 314.06 € | 5 770.56 € | 3 |
| 2020 Q1 | - | 4 172.75 € | 4 468.68 € | 3 |
